KPMA and KMA to agree over rebate issues.

Published: 2004-03-25 07:00:00

Updated: 2004-03-25 07:00:00

The pharmaceutical industry and the medical community have agreed to eliminate protracted irregularities related with drug supply deals between hospitals and drug industries, viewing it as the way for them to get people's credibility only when the drug supplies being dealt in transparency.

The...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK